EYPT, CRWV and EOSE Hit Fresh 52-Week Lows
EyePoint Pharmaceuticals, CoreWeave and Eos Energy Enterprises hit fresh 52-week lows Monday. A failed drug trial, debt refinancing concerns and weaker full-year revenue expectations weighed on the stocks; EyePoint fell 85%.